Our Team
Ariane Tom, PhD
Managing Director
Founder and Managing Director leading NeuroAI investments across BCI, neural data, and AI-driven brain technologies.
Srihari Sritharan, PhD
Venture Fellow
Venture Fellow driving high-impact neurotech and biopharma deals, including $100M+ and ~$1B partnerships across leading companies.
Evan Schnell, MBA
Venture Partner
Venture Partner with 25+ years in clinical software, BCI, and NeuroAI, scaling systems at Synchron and Medtronic.
Kevin Carlberg, PhD
Venture Partner
Venture Partner and former Meta AI director advancing applied AI, wearable tech, and NeuroAI systems.
Scientific Advisory Council
Innovators Powering the Neurotech Revolution
Tom Oxley
Synchron
Neurovascular and minimally invasive BCI, remote device control
Max Hodak
Science Corporation
Biohybrid BCI, neuroengineering, and vision restoration
Matt Angle
Paradromics
Neurovascular and minimally invasive BCI, remote device control
Sumner Norman
Merge Labs (Forest Neurotech)
Ultrasonic BCI, genetic engineering, AI co-development
Philip Sabes
Integral Neurotech
Robotic neurosurgery, prosthetics, and neuromodulation
Sergey Stavisky
UC Davis
Neuroprosthetics Lab
Speech and motor decoding through computational neuroscience and BCI
Justin Trotter
UC San Diego
Neurobiology
Synaptic and astrocyte–neuron signaling for psychiatry
Edward Wood
Austin Retina Associates
Visual perception, retinal therapeutics and ophthalmic device research